MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acr.24985

Медицинская библиотека · Arthritis care & research · 2023

Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.

Sotoodeh Romina, Waldman Lilach Eyal, Vigano Antonio, Moride Yola, Canac-Marquis Michelle, Spilak Tristan, Gamaoun Rihab, Kalaba Maja, Hachem Yasmina, Beaulieu Pierre, Desroches Julie, Ware Mark A, Perez Jordi, Shir Yoram, Fitzcharles Mary-Ann, Martel Marc O

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Many patients with fibromyalgia (FM) report using cannabis as a strategy to improve pain. Given that pain often co-occurs with symptoms of anxiety and depression (i.e., negative affect) and sleep problems among patients with FM, improvements in these symptoms might indirectly contribute to reductions in pain intensity following cannabis use. The main objective of the study was to examine whether changes in pain intensity following initiation of medical cannabis among patients with FM could be attributed to concurrent changes (i.e., reductions) in negative affect and sleep problems.

METHODS

This was a 12-month prospective cohort study among patients with FM (n = 323) initiating medical cannabis under the care of physicians. Patients were assessed at baseline, and follow-up assessment visits occurred every 3 months after initiation of medical cannabis. Patients' levels of pain intensity, negative affect, and sleep problems were assessed across all visits.

RESULTS

Multilevel mediation analyses indicated that reductions in patients' levels of pain intensity were partly explained by concurrent reductions in sleep problems and negative affect (both P < 0.001). This remained significant even when accounting for patients' baseline characteristics or changes in medical cannabis directives over time (all P > 0.05).

CONCLUSION

Our findings provide preliminary insight into the potential mechanisms of action underlying pain reductions among patients with FM who are using medical cannabis. Given the high attrition rate (i.e., 75%) observed in the present study at 12 months, our findings cannot be generalized to all patients with FM who are using medical cannabis.

Для цитирования: Sotoodeh Romina, Waldman Lilach Eyal, Vigano Antonio, Moride Yola, Canac-Marquis Michelle, Spilak Tristan, Gamaoun Rihab, Kalaba Maja, Hachem Yasmina, Beaulieu Pierre, Desroches Julie, Ware Mark A, Perez Jordi, Shir Yoram, Fitzcharles Mary-Ann, Martel Marc O. Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.. Arthritis care & research. 2023. DOI: 10.1002/acr.24985.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.